Cargando…

Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue

BACKGROUND: The mast cell is a crucial effector cell in allergic rhinitis and other inflammatory diseases. During the acute allergic reaction preformed mediators such as histamine, but also de novo produced mediators such as leukotrienes (LTC(4)/D(4)/E(4)) and prostaglandins (PGD(2)) are released. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Patou, Joke, Holtappels, Gabriele, Affleck, Karen, Gevaert, Philippe, Perez-Novo, Claudina, Van Cauwenberge, Paul, Bachert, Claus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674877/
https://www.ncbi.nlm.nih.gov/pubmed/19379488
http://dx.doi.org/10.1186/1476-9255-6-11
_version_ 1782166670107738112
author Patou, Joke
Holtappels, Gabriele
Affleck, Karen
Gevaert, Philippe
Perez-Novo, Claudina
Van Cauwenberge, Paul
Bachert, Claus
author_facet Patou, Joke
Holtappels, Gabriele
Affleck, Karen
Gevaert, Philippe
Perez-Novo, Claudina
Van Cauwenberge, Paul
Bachert, Claus
author_sort Patou, Joke
collection PubMed
description BACKGROUND: The mast cell is a crucial effector cell in allergic rhinitis and other inflammatory diseases. During the acute allergic reaction preformed mediators such as histamine, but also de novo produced mediators such as leukotrienes (LTC(4)/D(4)/E(4)) and prostaglandins (PGD(2)) are released. Mast cells represent targets for therapeutic intervention, and thus a human ex-vivo model to stimulate mast cells taken from mucosal sites would be instrumental for drug intervention studies. We have aimed to activate mast cells within ex-vivo human nasal tissue by IgE/anti-IgE specific (ε chain specific) stimulations and in this respect to test the usability of nasal polyps versus inferior turbinates METHODS: Biopsy samples were collected from patients with nasal polyps and inferior turbinates from patients who underwent sinus or septal surgery. Tissue fragments were primed with IgE 1 μg/ml for 60 minutes and then stimulated for 30 minutes with tissue culture medium (negative control), anti-IgE 10 μg/ml, anti-IgE 30 μg/ml and ionomycin 10 μM (positive control). Histamine, leukotrienes and PGD(2 )were measured in supernatants. To help provide an understanding of the extent of the response, the number of tryptase and FcεRIα positive cells was evaluated by means of immunohistochemistry and the FcεRIα-chain was measured by means of quantitative PCR in the nasal polyp and inferior turbinate tissues. Finally, the correlation between IgE concentrations in the nasal tissue and the release of mediators was analysed. RESULTS: Stimulations with anti-IgE on IgE-primed nasal tissue fragments lead to a concentration-dependent release of histamine, leukotrienes and PGD(2). The release of these early phase mediators was significantly higher in nasal polyps compared to inferior turbinates, although tryptase, FcεRIα positive cells and FcεRIα-chain transcripts were equally present in both groups. No correlation was found between baseline concentrations of IgE, and the release of histamine, LTC(4)/LTD(4)/LTE(4 )and PGD(2 )after stimulation. CONCLUSION: This human nasal challenge model mimics the allergic early phase reaction. The release of histamine, cys-leukotrienes and PGD(2 )was significantly higher in nasal polyps versus inferior turbinates, however, this observation could not be explained by differences in mast cell or FcεRI+ cell numbers.
format Text
id pubmed-2674877
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26748772009-04-30 Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue Patou, Joke Holtappels, Gabriele Affleck, Karen Gevaert, Philippe Perez-Novo, Claudina Van Cauwenberge, Paul Bachert, Claus J Inflamm (Lond) Research BACKGROUND: The mast cell is a crucial effector cell in allergic rhinitis and other inflammatory diseases. During the acute allergic reaction preformed mediators such as histamine, but also de novo produced mediators such as leukotrienes (LTC(4)/D(4)/E(4)) and prostaglandins (PGD(2)) are released. Mast cells represent targets for therapeutic intervention, and thus a human ex-vivo model to stimulate mast cells taken from mucosal sites would be instrumental for drug intervention studies. We have aimed to activate mast cells within ex-vivo human nasal tissue by IgE/anti-IgE specific (ε chain specific) stimulations and in this respect to test the usability of nasal polyps versus inferior turbinates METHODS: Biopsy samples were collected from patients with nasal polyps and inferior turbinates from patients who underwent sinus or septal surgery. Tissue fragments were primed with IgE 1 μg/ml for 60 minutes and then stimulated for 30 minutes with tissue culture medium (negative control), anti-IgE 10 μg/ml, anti-IgE 30 μg/ml and ionomycin 10 μM (positive control). Histamine, leukotrienes and PGD(2 )were measured in supernatants. To help provide an understanding of the extent of the response, the number of tryptase and FcεRIα positive cells was evaluated by means of immunohistochemistry and the FcεRIα-chain was measured by means of quantitative PCR in the nasal polyp and inferior turbinate tissues. Finally, the correlation between IgE concentrations in the nasal tissue and the release of mediators was analysed. RESULTS: Stimulations with anti-IgE on IgE-primed nasal tissue fragments lead to a concentration-dependent release of histamine, leukotrienes and PGD(2). The release of these early phase mediators was significantly higher in nasal polyps compared to inferior turbinates, although tryptase, FcεRIα positive cells and FcεRIα-chain transcripts were equally present in both groups. No correlation was found between baseline concentrations of IgE, and the release of histamine, LTC(4)/LTD(4)/LTE(4 )and PGD(2 )after stimulation. CONCLUSION: This human nasal challenge model mimics the allergic early phase reaction. The release of histamine, cys-leukotrienes and PGD(2 )was significantly higher in nasal polyps versus inferior turbinates, however, this observation could not be explained by differences in mast cell or FcεRI+ cell numbers. BioMed Central 2009-04-20 /pmc/articles/PMC2674877/ /pubmed/19379488 http://dx.doi.org/10.1186/1476-9255-6-11 Text en Copyright © 2009 Patou et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Patou, Joke
Holtappels, Gabriele
Affleck, Karen
Gevaert, Philippe
Perez-Novo, Claudina
Van Cauwenberge, Paul
Bachert, Claus
Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue
title Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue
title_full Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue
title_fullStr Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue
title_full_unstemmed Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue
title_short Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue
title_sort enhanced release of ige-dependent early phase mediators from nasal polyp tissue
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674877/
https://www.ncbi.nlm.nih.gov/pubmed/19379488
http://dx.doi.org/10.1186/1476-9255-6-11
work_keys_str_mv AT patoujoke enhancedreleaseofigedependentearlyphasemediatorsfromnasalpolyptissue
AT holtappelsgabriele enhancedreleaseofigedependentearlyphasemediatorsfromnasalpolyptissue
AT affleckkaren enhancedreleaseofigedependentearlyphasemediatorsfromnasalpolyptissue
AT gevaertphilippe enhancedreleaseofigedependentearlyphasemediatorsfromnasalpolyptissue
AT pereznovoclaudina enhancedreleaseofigedependentearlyphasemediatorsfromnasalpolyptissue
AT vancauwenbergepaul enhancedreleaseofigedependentearlyphasemediatorsfromnasalpolyptissue
AT bachertclaus enhancedreleaseofigedependentearlyphasemediatorsfromnasalpolyptissue